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Objective: To compare predeparture tuberculosis (TB) screening policies, including
screening criteria and screening tests, and visa requirements for prospective migrants to
high-income countries that have low to intermediate TB incidence and high immigration.
Study design: Systematic review of policy documents.
Methods: We systematically identified high-income, high net-migration countries with an
estimatedTB incidenceof<30per100,000.After initial selection, thisyielded15countrieswhich
potentially had TB screening policies. We performed a systematic search of governmental and
official visa services’ websites for these countries to identify visa information and policy doc-
uments for prospective migrants. Results were summarized, tabulated, and compared.
Results: Programs to screen for active TB were identified in all 15 countries, but screening
criteria and screening tests varied substantially between countries. Prospective migrants’
country of origin represented an initial assessment criterion which generally focused on
elevated TB incidence based on World Health Organization data but also focused on the
countries of origin that sent the most migrants, and this varied between destination
countries. Specific categories of migrants represented a second assessment criterion that
focused on duration of stay and reasons for migration; the focus of which showed variation
between the destination countries. Specific screening tests including medical examination
and chest X-rays were used as the final stage of assessment, and there were differences
between which tests were used between the destination countries.
Conclusions: Current approaches tomigrant TB screening are inconsistent in their approach and
implementation. While this variation might reflect adaptation to local public health situations,
it could also indicate uncertainty concerning optimal strategies. Comparative research studies
are needed to define the most effective and efficient methods for TB screening of migrants.
© 2019 The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public
Health. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).n, School of Population Health and Environmental Sciences, Addison House, Guy's Campus,
x: þ207 848 6620.
l.com (A. Garner-Purkis).
Elsevier Ltd on behalf of The Royal Society for Public Health. This is an open access article
tivecommons.org/licenses/by-nc-nd/4.0/).
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Global migration continues to increase. In 2017, it was esti-
mated that some 258 million people were living outside their
country of birth, up from 173 million in 2010.1 Migration re-
sults from ‘push’ factors that influence migrants' reasons for
leaving home countries and ‘pull’ factors that are associated
with the need for skilled and unskilled migrants in other
countries. The health of migrant populations is of increasing
concern. Tuberculosis (TB) is much more frequent in the low-
income countries that often provide a key source of migrant
labor for emerging markets and high-income countries. Mass
human migration creates an opportunity for infectious dis-
eases such as TB to spread from these high-incidence source
countries to low-incidence destination countries.2 In low-
incidence countries, migrants from high-incidence countries
account for a high proportion of new TB cases.3 As one
element of overall TB control efforts, governments of high-
income countries, particularly those with substantial in-
bound migration, have developed and implemented policies
to test migrants for possible active TB disease. These strate-
gies aim to reduce the spread of TB into the general popula-
tion. However, there is a lack of evidence concerning the
effectiveness of migrant screening.4 There is also uncertainty
concerning the selection of migrants for testing and the
screening tests to be employed.5,6 This study aimed to
compare TB screening policies, including screening criteria
and screening tests, and related visa requirements for mi-
grants in selected high-income countries with intermediate-
to-low incidence of TB and high levels of in-bound migra-
tion. As the countries have high inbound migration, this pro-
vides potentially greater motivation to control imported
infectious diseases and thereforemade itmore likely that they
would have specific TB screening procedures for migrants.Methods
Focus and search strategy
For the purpose of this review, we define ‘migrants’ as persons
migrating for work, education, or for family reasons,7 in which
the individual has taken an official path to migrate (tempo-
rarily or permanently) to the destination country. To identify
policy documents for countries where TB screening of mi-
grants is of relevance, we initially identified countries with TB
incidence of <30 per 100,000 as perWorld Health Organization
(WHO) 2016 data, World Bank income category ‘high-income’
and netmigration of10,000 per year.We performed an initial
review of European Union countries based on previous pub-
lished literature3,5,6,8,9, and an internet search. One author
(AGP) systematically searched government websites for each
country to identify TB screening guidelines and visa infor-
mation for prospective migrants. Documents were identified
in French, Spanish, and English and translated accordingly.
We contacted government ministries directly to request
further information where required. For Chile and Saudi
Arabia, the visa information for migrants is organized by
country of origin and data for these countries were taken fromwebpages of their UK Embassy. Additionally, the search
included documents from the Gulf Cooperation Council (GCC)
which provides policy guidance for the Gulf States.
Data analysis and synthesis
Data were extracted from source documents (Appendix).
Initial appraisal identified three common approaches to
migrant TB screening for each destination country. These
included selection for screening according to migrant country
of origin, selection based on the circumstances of themigrant's
visit, and selection of TB screening tests.We extracted data for
each of these aspects, tabulated data, and made comparisons
to enable synthesis of our findings. All the countries were
searched for following the same steps and were found to have
the same common features as discussed above.Results
We identified screening programs for active TB in all 15
selected countries and in the GCC guidelines. We identified
predeparture screening for prospective migrants for 14 of the
15 countries, only Japan did not require predeparture
screening. Table 1 presents the predeparture screening re-
quirements and tests for the remaining 14 countries and the
GCC. Screening guidelines at the predeparture stage employed
three levels of assessment, focusing on screening criteria and
screening tests including selection by country of migrant
origin andmigrant category, and the selection of TB screening
tests. Thus, the screening process can be conceptualized as
using migrant origins and migrant categories as initial
screening criteria with TB screening tests reserved for mi-
grants from groups deemed to be at higher risk.
Country of migrant origin
The 14 destination countries usedmigrant country of origin to
identify individuals for predeparture TB screening. However,
destination countries varied widely in the target migrant
countries of origin that they selected for screening and on the
evidence used to guide this decision. Four countries used
WHO-defined high TB incidence, but this ranged from esti-
mated TB incidence of 20 cases per 100,000 population for
the USA to estimated TB incidence of 40 cases per 100,000
population for the UK. New Zealand screened migrants from
countries that were not included on a list of countries with a
low-incidence of TB, though the source for these estimates
was not identified. The other countries had different reasons
for their decisions to screen different migrants: two countries
screened migrants from all countries; three countries did not
clearly state the reasons for the decision; and four destination
countries selected those countries of origin sending the most
migrants. These destination countries were all Gulf States. In
the GCC policy document, 11 countries of origin were identi-
fied as requiring to have predeparture health screening pro-
grams in place in order for migrants to work in the Gulf states.
The reasons given are that three million migrant workers
come from these 11 countries, and these tests are used to
ensure physical fitness.
Table 1 e Comparison of active TB screening assessment criteria for countries included in the review.
Destination
country
Origin countries selected (basis for
country selection)
Migrant categories selected Screening tests used
Australia China, India, Indonesia, Malaysia,
Pakistan, Philippines, Russia, South
Africa, South Korea, Thailand, and
Vietnam (Based on WHO data)
Length of stay: temporary entry: >3
months
CXR (aged 11+ years)
Bahrain All countries: required GAMCA clinics
only: Bangladesh, Egypt, Ethiopia, India,
Indonesia, Nepal, Pakistan, Philippines,
Sri Lanka, Sudan, and Syria
Category of visa: Expatriate job
applicant
Medical examination; CXR
Canada Any country that meets the WHO 2009
definition. (WHO 2009 definition of high
TB incidence, 30 per 100,000 for all forms
of active TB [3-year average]).
Length of stay: temporary: >6
months stay residence: + have
spent 6 or more consecutive
months in high TB incidence
country
Medical examination; CXR
(aged 11+ years)b
Chile a Category of visa + length of stay:
work contract, student for >90
days, temporary residence (work,
study, and family)
Medical examination
GCC Bangladesh, Egypt, Ethiopia, India,
Indonesia, Nepal, Pakistan, Philippines,
Sri Lanka, Sudan, and Syria
Not mentioned Medical examination; CXR
France Armenia, Cameroon, Mali, Morocco,
Senegal, Tunisia, Turkey, and Romania
Category of visa: family
reunification
Medical examination; CXR; verification of
vaccination status
Israel All countries Category of visa: work visa
approved for limited period of time
Applicants must obtain a ‘certificate of
medical examination including normal
results in tests for tuberculosis’
Destination
country
Origin countries selected (basis
for country selection)
Migrant categories selected Screening tests used
Kuwait All countries Category of visa: all except private
or government working entrance
visa or temporary residence
Not stated
New Zealand If not listed as low-incidence TB
countries (54 countries)
Length of stay + category of visa: 6
months or more (student/worker)
Medical examination; CXRc
Oman India, Pakistan, Philippines,
Bangladesh, Indonesia, Sri Lanka,
Egypt, Syria, Sudan, and Ethiopia
Category of visa: for employment
and family residence (aged
21+ years), Student
Not stated
Qatar Bangladesh, Egypt, Ethiopia, India,
Indonesia, Nepal, Pakistan,
Philippines, Sri Lanka, and Sudan
Category of visa: job seekers Not stated
Saudi Arabia a Category of visa: job seekers (not
for family or student visas)
Medical examination; CXR
UAE (Abu-Dhabi) Indonesia, Sri Lanka, and Ethiopia Category of visa: all migrants
intending to apply for a UAE visa
CXR (18 + years)
UK 102 countries (countries where
WHO estimated TB incidence 40
per 100,000 population)
Length of stay: 6 months or more CXR abnormal CXR: sputum smear
USA WHO estimated TB incidence of
20 cases per 100,000 population
All and if 2e14 years and from
high-incidence country more
clinical screening required
Medical examination; CXR (aged 15+ years)d
GCC ¼ Gulf Cooperation Council; GAMCA* ¼ Gulf Approved Medical Clinics Association; UAE ¼ United Arab Emirates; CXR ¼ chest X-ray.
*GAMCAdan association established to provide medical examinations to those seeking work to join labor market in the GCC countries.*1
*1 International Labor Organization., 2016. Law and Practice: The recruitment of low-skilled Pakistani workers for overseas employment. Pakistan: In-
ternational Labor Organization.
a Amedical report was required for the UK and USA; however, owing to the available information only being accessible on each country's Saudi
Arabian embassy website, this was not able to be checked for every country. This was the same for Chile.
b For those with evidence of previous TB, suspicious CXR or not screened due to pregnancy.
c For individuals from or having visited a country that is not low-incidence for TB/spent more than 3months in the last 5 years in a country not
at low-incidence for TB.
d If symptoms of TB or they have HIV, then required to complete three sputum specimens.
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There were 13 countries that used the circumstances of the
migrant's visit to determine the need for screening. Three
countries used length of stay as a criterion (for Australia, those
seeking entry of greater than three months, required TB
screening if they originated from designated countries of
origin); eight countries used category of visa (Qatar used cate-
gory of visawith job seekers from selected countries required to
have TB screening); two countries used a combination of length
of stay and category of visa (Chile used both criteriadfor a
student staying longer than 90 days screening was required).
These categorizations were used in conjunction with the
country of origin to select migrants for individual TB screening.
Screening tests used
The TB testing procedures required by countries and the GCC
are outlined in Table 1. Most countries employed a combina-
tion of medical examination and chest X-ray to identify
possible cases of TB. Chile did not specifically require a chest
X-ray but required a medical report to certify that the appli-
cant did not have contagious diseases. Three countries,
including the UK, employed the chest X-ray alone as the pri-
mary screening procedure for TB. Several countries also set a
lower age limit, ranging from 11 to 18 years, on the require-
ment for a chest X-ray. The specification of medical exami-
nation requirements also varied between countries: Canada
recommended specific questions concerning symptoms of
pulmonary TB, while in other countries, the form of exami-
nation was less clearly specified.Discussion
Main findings
The review identified 15 countries with screening programs
for active TB for migrants. Predeparture screening involves
three levels of initial assessment including (1) country of
migrant origin, (2) migrant category, and (3) TB screening
tests. These factors determine whichmigrants require further
TB screening. We identified considerable variation in both
initial assessment, including by country of origin, and inmode
of further clinical assessment.
Strengths and limitations
This represents the first study to systematically review
screening for prospectivemigrants using national policies and
visa instructions for the migrants. Restricting our search to
public websites and language restrictions may have intro-
duced ascertainment bias. However, this mirrors the experi-
ence of potential migrants and clinicians providing
predeparture screening.
Variability in screening policy and justice
The wide variability is indicative of uncertainty concerning
optimal policies and suggests that countries screen based oncriteria which may not be evidence-based. Any screening
program requires careful assessment of possible benefits
and harms. Predeparture TB screening differs from mass
population screening in that it is a precautionary step taken
before individuals enter the destination country. There are
certain selective criteria for who should be screened, and
there is no choice for the population being screened. This
raises the question of acceptability and ethics of the
screening program for the migrant population. In migrants'
countries of origin, confirmatory tests may be expensive to
access, and TB treatment and follow-up may not always be
easily accessible, consistent or free of charge. By requiring
access to TB testing, predeparture screening might also
benefit the migrant's country of origin, if this facilitates
detection and treatment of TB. While there are no studies to
date that specifically evaluated the acceptability of prede-
parture screening, a study in East London10 showed that TB
screening had high acceptability in migrants following
arrival. It was valued and viewed as a socially responsible
activity.
Conclusion
This review highlights a lack of standardization of TB
screening policies across a range of high-income coun-
tries. This variation might be partly explained by contex-
tual differences between countries, including differences
in the numbers and origins of prospective migrants. This
variation may also reflect a lack of clear evidence as to
which approach is more efficient and cost-effective at
identifying migrants with active TB, because trials and
other suitable comparative studies have not been con-
ducted. The variations identified in this review demon-
strate that it is not known which approaches are most
effective and efficient for detecting TB in migrant pop-
ulations. Prospective comparative effectiveness studies are
required to provide evidence concerning the optimal TB
screening policies.Author statements
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